Search research articles
Contact Us
Filters
Showing results (141-150 of 184) with videos related to
Page
of 19
Sort By:
Blood
|
April 1, 1986
Relationship of the clinical response and binding of recombinant interferon alpha in patients with lymphoproliferative diseases
C R Faltynek, G L Princler, J L Rossio, et al.
The American Journal of Medicine
|
February 1, 1985
Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia
K A Foon, G C Bottino, P G Abrams, et al.
Journal of Biological Response Modifiers
|
December 1, 1984
A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer
S A Sherwin, K A Foon, P G Abrams, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1983
The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administration
J A Knost, S A Sherwin, P G Abrams, et al.
Cancer Research
|
December 15, 1990
Biodistribution, pharmacokinetic, and imaging studies with 186Re-labeled NR-LU-10 whole antibody in LS174T colonic tumor-bearing mice
M H Goldrosen, W C Biddle, J Pancook, et al.
Annals of Internal Medicine
|
May 1, 1983
Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial
S A Sherwin, D Mayer, J J Ochs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen
K A Foon, W J John, M Chakraborty, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1985
A phase I trial of recombinant gamma interferon in patients with cancer
K A Foon, S A Sherwin, P G Abrams, et al.
Molecular Imaging and Biology
|
September 6, 2008
Radioisotopic localization of (90)Yttrium-ibritumomab tiuxetan in patients with CD20+ non-Hodgkin's lymphoma
S A Jacobs, A M Harrison, S H Swerdlow, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
April 1, 1992
Renal cell carcinoma treated with continuous-infusion interleukin-2 with ex vivo-activated killer cells
K A Foon, P J Walther, Z P Bernstein, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 184) with videos related to
Sort By:
Page
of 19
Blood
|
April 1, 1986
Relationship of the clinical response and binding of recombinant interferon alpha in patients with lymphoproliferative diseases
C R Faltynek, G L Princler, J L Rossio, et al.
The American Journal of Medicine
|
February 1, 1985
Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia
K A Foon, G C Bottino, P G Abrams, et al.
Journal of Biological Response Modifiers
|
December 1, 1984
A preliminary Phase I trial of partially purified interferon-gamma in patients with cancer
S A Sherwin, K A Foon, P G Abrams, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1983
The treatment of cancer patients with human lymphoblastoid interferon. A comparison of two routes of administration
J A Knost, S A Sherwin, P G Abrams, et al.
Cancer Research
|
December 15, 1990
Biodistribution, pharmacokinetic, and imaging studies with 186Re-labeled NR-LU-10 whole antibody in LS174T colonic tumor-bearing mice
M H Goldrosen, W C Biddle, J Pancook, et al.
Annals of Internal Medicine
|
May 1, 1983
Recombinant leukocyte A interferon in advanced breast cancer. Results of a phase II efficacy trial
S A Sherwin, D Mayer, J J Ochs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Clinical and immune responses in resected colon cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen
K A Foon, W J John, M Chakraborty, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1985
A phase I trial of recombinant gamma interferon in patients with cancer
K A Foon, S A Sherwin, P G Abrams, et al.
Molecular Imaging and Biology
|
September 6, 2008
Radioisotopic localization of (90)Yttrium-ibritumomab tiuxetan in patients with CD20+ non-Hodgkin's lymphoma
S A Jacobs, A M Harrison, S H Swerdlow, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
April 1, 1992
Renal cell carcinoma treated with continuous-infusion interleukin-2 with ex vivo-activated killer cells
K A Foon, P J Walther, Z P Bernstein, et al.
Page
of 19